カテゴリー： QYResearch, 世界, 医療/バイオ

世界の糖尿病検査用穿刺器具市場インサイト及び予測（調整可能式穿刺器具、調整不可能式穿刺器具）

◆英語タイトル：Global Lancing Device for Diabetes Testing Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09636）◆商品コード：QY22JLX09636
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、糖尿病検査用穿刺器具のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糖尿病検査用穿刺器具の世界市場のxxx％を占める「調整可能式穿刺器具」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「在宅医療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
糖尿病検査用穿刺器具の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの糖尿病検査用穿刺器具市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

糖尿病検査用穿刺器具のグローバル主要企業には、Medtronic、Roche、Owen Mumford、Lifescan、Ascensia、Accu-Chek、B. Braun Medical、Terumo、BIONIME、Sinocare、Lobeck Medical AG、GMMC Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

糖尿病検査用穿刺器具市場は、種類と用途によって区分されます。世界の糖尿病検査用穿刺器具市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
調整可能式穿刺器具、調整不可能式穿刺器具

【用途別セグメント】
在宅医療、病院・クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 糖尿病検査用穿刺器具製品概要
- 種類別市場（調整可能式穿刺器具、調整不可能式穿刺器具）
- 用途別市場（在宅医療、病院・クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の糖尿病検査用穿刺器具販売量予測2017-2028
- 世界の糖尿病検査用穿刺器具売上予測2017-2028
- 糖尿病検査用穿刺器具の地域別販売量
- 糖尿病検査用穿刺器具の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別糖尿病検査用穿刺器具販売量
- 主要メーカー別糖尿病検査用穿刺器具売上
- 主要メーカー別糖尿病検査用穿刺器具価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（調整可能式穿刺器具、調整不可能式穿刺器具）
- 糖尿病検査用穿刺器具の種類別販売量
- 糖尿病検査用穿刺器具の種類別売上
- 糖尿病検査用穿刺器具の種類別価格
・用途別市場規模（在宅医療、病院・クリニック）
- 糖尿病検査用穿刺器具の用途別販売量
- 糖尿病検査用穿刺器具の用途別売上
- 糖尿病検査用穿刺器具の用途別価格
・北米市場
- 北米の糖尿病検査用穿刺器具市場規模（種類別、用途別）
- 主要国別の糖尿病検査用穿刺器具市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの糖尿病検査用穿刺器具市場規模（種類別、用途別）
- 主要国別の糖尿病検査用穿刺器具市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の糖尿病検査用穿刺器具市場規模（種類別、用途別）
- 主要国別の糖尿病検査用穿刺器具市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の糖尿病検査用穿刺器具市場規模（種類別、用途別）
- 主要国別の糖尿病検査用穿刺器具市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの糖尿病検査用穿刺器具市場規模（種類別、用途別）
- 主要国別の糖尿病検査用穿刺器具市場規模（トルコ、サウジアラビア）
・企業情報
Medtronic、Roche、Owen Mumford、Lifescan、Ascensia、Accu-Chek、B. Braun Medical、Terumo、BIONIME、Sinocare、Lobeck Medical AG、GMMC Group
・産業チェーン及び販売チャネル分析
- 糖尿病検査用穿刺器具の産業チェーン分析
- 糖尿病検査用穿刺器具の原材料
- 糖尿病検査用穿刺器具の生産プロセス
- 糖尿病検査用穿刺器具の販売及びマーケティング
- 糖尿病検査用穿刺器具の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 糖尿病検査用穿刺器具の産業動向
- 糖尿病検査用穿刺器具のマーケットドライバー
- 糖尿病検査用穿刺器具の課題
- 糖尿病検査用穿刺器具の阻害要因
・主な調査結果

Market Analysis and Insights: Global Lancing Device for Diabetes Testing Market
Due to the COVID-19 pandemic, the global Lancing Device for Diabetes Testing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Adjustable Lancing Device accounting for % of the Lancing Device for Diabetes Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Home Care segment is altered to an % CAGR throughout this forecast period.
China Lancing Device for Diabetes Testing market size is valued at US$ million in 2021, while the US and Europe Lancing Device for Diabetes Testing are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lancing Device for Diabetes Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Lancing Device for Diabetes Testing include Medtronic, Roche, Owen Mumford, Lifescan, Ascensia, Accu-Chek, B. Braun Medical, Terumo and BIONIME, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Lancing Device for Diabetes Testing Scope and Segment
Lancing Device for Diabetes Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lancing Device for Diabetes Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Home Care
Hospital & Clinics
By Company
Medtronic
Roche
Owen Mumford
Lifescan
Ascensia
Accu-Chek
B. Braun Medical
Terumo
BIONIME
Sinocare
Lobeck Medical AG
GMMC Group
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Lancing Device for Diabetes Testing Product Introduction
1.2 Market by Type
1.2.1 Global Lancing Device for Diabetes Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adjustable Lancing Device
1.2.3 Non-adjustable Lancing Device
1.3 Market by Application
1.3.1 Global Lancing Device for Diabetes Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home Care
1.3.3 Hospital & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lancing Device for Diabetes Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Lancing Device for Diabetes Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Lancing Device for Diabetes Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lancing Device for Diabetes Testing Sales by Region
2.4.1 Global Lancing Device for Diabetes Testing Sales by Region (2017-2022)
2.4.2 Global Sales Lancing Device for Diabetes Testing by Region (2023-2028)
2.5 Global Lancing Device for Diabetes Testing Revenue by Region
2.5.1 Global Lancing Device for Diabetes Testing Revenue by Region (2017-2022)
2.5.2 Global Lancing Device for Diabetes Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lancing Device for Diabetes Testing Sales by Manufacturers
3.1.1 Global Top Lancing Device for Diabetes Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Lancing Device for Diabetes Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lancing Device for Diabetes Testing in 2021
3.2 Global Lancing Device for Diabetes Testing Revenue by Manufacturers
3.2.1 Global Lancing Device for Diabetes Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Lancing Device for Diabetes Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lancing Device for Diabetes Testing Revenue in 2021
3.3 Global Lancing Device for Diabetes Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lancing Device for Diabetes Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lancing Device for Diabetes Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lancing Device for Diabetes Testing Sales by Type
4.1.1 Global Lancing Device for Diabetes Testing Historical Sales by Type (2017-2022)
4.1.2 Global Lancing Device for Diabetes Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Lancing Device for Diabetes Testing Sales Market Share by Type (2017-2028)
4.2 Global Lancing Device for Diabetes Testing Revenue by Type
4.2.1 Global Lancing Device for Diabetes Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Lancing Device for Diabetes Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lancing Device for Diabetes Testing Revenue Market Share by Type (2017-2028)
4.3 Global Lancing Device for Diabetes Testing Price by Type
4.3.1 Global Lancing Device for Diabetes Testing Price by Type (2017-2022)
4.3.2 Global Lancing Device for Diabetes Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lancing Device for Diabetes Testing Sales by Application
5.1.1 Global Lancing Device for Diabetes Testing Historical Sales by Application (2017-2022)
5.1.2 Global Lancing Device for Diabetes Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Lancing Device for Diabetes Testing Sales Market Share by Application (2017-2028)
5.2 Global Lancing Device for Diabetes Testing Revenue by Application
5.2.1 Global Lancing Device for Diabetes Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Lancing Device for Diabetes Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lancing Device for Diabetes Testing Revenue Market Share by Application (2017-2028)
5.3 Global Lancing Device for Diabetes Testing Price by Application
5.3.1 Global Lancing Device for Diabetes Testing Price by Application (2017-2022)
5.3.2 Global Lancing Device for Diabetes Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lancing Device for Diabetes Testing Market Size by Type
6.1.1 North America Lancing Device for Diabetes Testing Sales by Type (2017-2028)
6.1.2 North America Lancing Device for Diabetes Testing Revenue by Type (2017-2028)
6.2 North America Lancing Device for Diabetes Testing Market Size by Application
6.2.1 North America Lancing Device for Diabetes Testing Sales by Application (2017-2028)
6.2.2 North America Lancing Device for Diabetes Testing Revenue by Application (2017-2028)
6.3 North America Lancing Device for Diabetes Testing Market Size by Country
6.3.1 North America Lancing Device for Diabetes Testing Sales by Country (2017-2028)
6.3.2 North America Lancing Device for Diabetes Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lancing Device for Diabetes Testing Market Size by Type
7.1.1 Europe Lancing Device for Diabetes Testing Sales by Type (2017-2028)
7.1.2 Europe Lancing Device for Diabetes Testing Revenue by Type (2017-2028)
7.2 Europe Lancing Device for Diabetes Testing Market Size by Application
7.2.1 Europe Lancing Device for Diabetes Testing Sales by Application (2017-2028)
7.2.2 Europe Lancing Device for Diabetes Testing Revenue by Application (2017-2028)
7.3 Europe Lancing Device for Diabetes Testing Market Size by Country
7.3.1 Europe Lancing Device for Diabetes Testing Sales by Country (2017-2028)
7.3.2 Europe Lancing Device for Diabetes Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lancing Device for Diabetes Testing Market Size by Type
8.1.1 Asia Pacific Lancing Device for Diabetes Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Lancing Device for Diabetes Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Lancing Device for Diabetes Testing Market Size by Application
8.2.1 Asia Pacific Lancing Device for Diabetes Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Lancing Device for Diabetes Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Lancing Device for Diabetes Testing Market Size by Region
8.3.1 Asia Pacific Lancing Device for Diabetes Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Lancing Device for Diabetes Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lancing Device for Diabetes Testing Market Size by Type
9.1.1 Latin America Lancing Device for Diabetes Testing Sales by Type (2017-2028)
9.1.2 Latin America Lancing Device for Diabetes Testing Revenue by Type (2017-2028)
9.2 Latin America Lancing Device for Diabetes Testing Market Size by Application
9.2.1 Latin America Lancing Device for Diabetes Testing Sales by Application (2017-2028)
9.2.2 Latin America Lancing Device for Diabetes Testing Revenue by Application (2017-2028)
9.3 Latin America Lancing Device for Diabetes Testing Market Size by Country
9.3.1 Latin America Lancing Device for Diabetes Testing Sales by Country (2017-2028)
9.3.2 Latin America Lancing Device for Diabetes Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lancing Device for Diabetes Testing Market Size by Type
10.1.1 Middle East and Africa Lancing Device for Diabetes Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lancing Device for Diabetes Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Lancing Device for Diabetes Testing Market Size by Application
10.2.1 Middle East and Africa Lancing Device for Diabetes Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lancing Device for Diabetes Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Lancing Device for Diabetes Testing Market Size by Country
10.3.1 Middle East and Africa Lancing Device for Diabetes Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lancing Device for Diabetes Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Owen Mumford
11.3.1 Owen Mumford Corporation Information
11.3.2 Owen Mumford Overview
11.3.3 Owen Mumford Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Owen Mumford Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Owen Mumford Recent Developments
11.4 Lifescan
11.4.1 Lifescan Corporation Information
11.4.2 Lifescan Overview
11.4.3 Lifescan Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lifescan Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lifescan Recent Developments
11.5 Ascensia
11.5.1 Ascensia Corporation Information
11.5.2 Ascensia Overview
11.5.3 Ascensia Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ascensia Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ascensia Recent Developments
11.6 Accu-Chek
11.6.1 Accu-Chek Corporation Information
11.6.2 Accu-Chek Overview
11.6.3 Accu-Chek Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Accu-Chek Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Accu-Chek Recent Developments
11.7 B. Braun Medical
11.7.1 B. Braun Medical Corporation Information
11.7.2 B. Braun Medical Overview
11.7.3 B. Braun Medical Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 B. Braun Medical Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 B. Braun Medical Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Overview
11.8.3 Terumo Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Terumo Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Terumo Recent Developments
11.9 BIONIME
11.9.1 BIONIME Corporation Information
11.9.2 BIONIME Overview
11.9.3 BIONIME Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BIONIME Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BIONIME Recent Developments
11.10 Sinocare
11.10.1 Sinocare Corporation Information
11.10.2 Sinocare Overview
11.10.3 Sinocare Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sinocare Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sinocare Recent Developments
11.11 Lobeck Medical AG
11.11.1 Lobeck Medical AG Corporation Information
11.11.2 Lobeck Medical AG Overview
11.11.3 Lobeck Medical AG Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lobeck Medical AG Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lobeck Medical AG Recent Developments
11.12 GMMC Group
11.12.1 GMMC Group Corporation Information
11.12.2 GMMC Group Overview
11.12.3 GMMC Group Lancing Device for Diabetes Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 GMMC Group Lancing Device for Diabetes Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GMMC Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lancing Device for Diabetes Testing Industry Chain Analysis
12.2 Lancing Device for Diabetes Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lancing Device for Diabetes Testing Production Mode & Process
12.4 Lancing Device for Diabetes Testing Sales and Marketing
12.4.1 Lancing Device for Diabetes Testing Sales Channels
12.4.2 Lancing Device for Diabetes Testing Distributors
12.5 Lancing Device for Diabetes Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lancing Device for Diabetes Testing Industry Trends
13.2 Lancing Device for Diabetes Testing Market Drivers
13.3 Lancing Device for Diabetes Testing Market Challenges
13.4 Lancing Device for Diabetes Testing Market Restraints
14 Key Findings in The Global Lancing Device for Diabetes Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の糖尿病検査用穿刺器具市場インサイト及び予測（調整可能式穿刺器具、調整不可能式穿刺器具）(Global Lancing Device for Diabetes Testing Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 無痛穿刺装置のグローバル市場予測2023-2029
  • 世界のネットワークポイントオブケアグルコース検査装置市場インサイト及び予測（0.5uL / 0.6uL、1uL、1.5uL、その他）
  • 世界の糖尿病検査プログラム市場インサイト及び予測（機器、検査キット、試薬）
  • 世界の糖尿病用デジタルツール市場インサイト及び予測（医療機器、仮想ツール）
  • 世界の糖尿病用穿刺器具市場2022年：押しボタン式安全ランセット、圧力作動式安全ランセット、サイドボタン式安全ランセット